Correlation Between Hemoglobin Levels, Hematocrit With Serum Erythropoietin In Erythrocytosis Patients

Authors

  • Didik Agus Santoso Clinical Pathology Subspecialization Programme, Department of Clinical Pathology, Faculty of Medicine Airlangga University, Surabaya, Indonesia
  • Muhamad Robi’ul Fuadi Department of Clinical Pathology, Faculty of Medicine Airlangga University, Surabaya, Indonesia

DOI:

https://doi.org/10.14738/bjhmr.106.16003

Keywords:

Erythrocytosis, hemoglobin levels, hematocrit, serum erythropoietin

Abstract

Background: Erythrocytosis is a condition where hemoglobin and hematocrit levels increase, in men (>16.5 g/dL; >49%) and women (>16.0 g/dL; >48%). Erythrocytosis results from an absolute increase in erythrocyte mass (absolute erythrocytosis/polycythemia), either primary or secondary, and as a result of a decrease in plasma volume (relative erythrocytosis). The prevalence of primary erythrocytosis in America is approximately 44 per 100,000 people. The incidence is most common in men, young adults to old age. The prevalence of secondary erythrocytosis is difficult to estimate and is much higher but data are limited and the causes are diverse. The condition of erythrocytosis is at risk of vascular complications and thrombosis. The diagnosis of polycythemia in erythrocytosis patients requires a confirmatory examination of the JAK2 V617F mutation which is expensive and laboratories rarely carry it out, so an alternative erythropoietin examination is needed to differentiate primary or secondary erythrocytosis. Objective: This study aims to analyze the correlation between hemoglobin levels, hematocrit and serum erythropoietin in erythrocytosis patients. Methode: This research is an observational study-cross sectional, with measurements of serum hemoglobin, hematocrit and erythropoietin levels in erythrocytosis patients taken by simple random sampling, in Dr Darsono Hospital, Pacitan Regency. Statistical analysis used the SPSS program with the Pearson correlation test. Result: The number of samples was: 56 samples, with characteristics: 89% men and an average age of 46 years. Average hemoglobin level: 17.3 mg/dL, hematocrit: 50.3% and average erythropoietin: 0.67 mIU/mL (reference value: 2.9-5.0 mIU/mL), lowest level 0.01 mIU/mL and highest 4.62 mIU/mL. The results of the correlation analysis found that there was an insignificant correlation between hemoglobin levels and serum erythropoietin (r= 0.165 and p= 0.256). There was a non-significant correlation between hematocrit and serum erythropoietin (r= 0.115 and p= 0.431). Discussion: There were low mean erythropoietin levels in the erythrocytosis patients in this study. There was an insignificant correlation between hemoglobin levels, hematocrit and serum erythropoietin in erythrocytosis patients. Conclusion: Serum erythropoietin examination is needed to screen for primary and secondary causes of erythrocytosis, before carrying out further examination with the JAK2 V617F mutation as confirmation of primary erythrocytosis (polycythemia vera).

References

Keohane C, Mullin MF, Harrison C. The Diagnosis and Management of Erythrocytosis. The British Medical Journal (BMJ). 2013;347.

Prcal JT. Primary and Secondary Polychythemias. William Hematology, 9th edition, Chapter 57. McGraw-Hill Education. 2016;871-885

Mullin MF, Mead AJ, Ali S, et al. A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis. A British Society for Haematology Guideline. British Journal of Haematology. 2019;184:161-175.

Nagalla S. Secondary Polycythemia Workup. Emedicine Medscape. 2022.

Spivak JL, Agbedia OO. Serum Erythropoietin Levels in Patients With Erythrocytosis With JAK2 Mutation. American Journal of Hematology. 2022;1-5.

Geyer HL, Koslorek H, Dueck AC, et al. Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group. Haematologica. 2017;102(1): 85-93.

Verstovsek S, Agbedia OO. Diagnostic Performances of Serum Erythropoietin Level and JAK2 Mutation for Polycythemias. British Journal of Haematology. 2021;1-3. 62 Santoso, D. A., & Fuadi, M. R. (2023). Correlation Between Hemoglobin Levels, Hematocrit with Serum Erythropoietin in Erythrocytosis Patients. British Journal of Healthcare and Medical Research, Vol - 10(6). 59-63.

Gonzalez DD, Ruiz AB, Fountain E, et al. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center. Clinical lymphoma myeloma leukemia. 2021;21(4):224-229

Mullin MF, Harrison CN, Ali S, et al. A guideline for diagnosisis and management of polycythaemia vera. A British Society for Haematology Guideline. British Journal of Haematology. 2019;184:176-191.

Downloads

Published

2023-12-17

How to Cite

Santoso, D. A., & Fuadi, M. R. (2023). Correlation Between Hemoglobin Levels, Hematocrit With Serum Erythropoietin In Erythrocytosis Patients. British Journal of Healthcare and Medical Research, 10(6), 59–63. https://doi.org/10.14738/bjhmr.106.16003